Aditxt News and Activities

View the org chart displaying its 18 main executives

Most searched biographies at Aditxt

• Jeffrey Busch, Interim Chief Executive Officer
• Sylvia Hermina, Director
• Charles Nelson, Director

Popular executive movements at Aditxt

• Christopher Porcelli, General Counsel & Chief People Officer, has left the company  (posted on June 8 2026).
• Brian Brady, Non-Executive Chairman and director, has left the company  (posted on June 8 2026).
• Jeffrey Busch has joined the company as Interim Chief Executive Officer  (posted on June 1 2026).

Click here to view some more movements at Aditxt

Create your alert
to follow the executive moves at Aditxt.

Aditxt has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Aditxt

• News
• Press Releases

Social media about Aditxt

• Aditxt on Wikipedia, Google News & Yahoo Finance
• Aditxt on LinkedIn, X (Twitter) & YouTube